Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions

AIM: To evaluate the efficacy of glycopyrrolate oral solution (1 mg/5 mL) in managing problem drooling associated with cerebral palsy and other neurologic conditions. METHOD: Thirty-eight patients aged 3–23 years weighing at least 27 lb (12.2 kg) with severe drooling (clothing damp 5–7 days/week) we...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeller, Robert S, Lee, Hak-Myung, Cavanaugh, Paul F, Davidson, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269347/
https://www.ncbi.nlm.nih.gov/pubmed/22298950
http://dx.doi.org/10.2147/TCRM.S26893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269347/
https://www.ncbi.nlm.nih.gov/pubmed/22298950
http://dx.doi.org/10.2147/TCRM.S26893

Ejemplares similares